Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
BPC-157 reconstitution typically uses 12 mL of bacteriostatic water per 5 mg vial, producing a concentration of 2.55 mg/mL
Beyond Use Date Up to 120 Days from compounding (USP ) Use within this window from the date your vial is compounded
Reconstitute: Add 1.0 mL bacteriostatic water ~ 10.0 mg/mL concentration
Because retatrutide is not yet licensed in the UK, it is not routinely available for prescribing outside a clinical trial or a specific MHRA access scheme (such as the Early Access to Medicines Scheme [EAMS] or named-patient unlicensed supply)
We use the medicine to treat the potential symptoms of suboptimal vitamin B12 levels and to protect the health of those following a Plant Based Diet absent in the vitamin
Transparency, Testing & Traceability Every batch of BPC-157 we supply is independently tested before it reaches a researchers laboratory
US$ 21.73
US$ 20.50
US$ 25.34
